Navigation Links
PediaVision to Conduct Spot Demonstrations During American Academy of Ophthalmology Annual Meeting
Date:10/18/2011

LAKE MARY, Fla., Oct. 18, 2011 /PRNewswire/ --WHO:David Melnik, President & CEO of PediaVisionJeff Mortensen, Vice President of PediaVisionWHAT:Will be conducting demonstrations of Spot, a revolutionary new vision screening device, which identifies vision problems in less than one second.WHEN:Wednesday, October 19, Thursday, October 20, Friday October 21 WHY:Spot is a new breakthrough vision screening device that will help children across America.  Spot has an incredibly quick capture time of less than one second which makes screening equally efficient in a physician's office or large-scale public screening. Spot is easily used by anyone when screening children from 6 months through adults.  URGENCY:

There is an on-going and urgent need for Spot.  The U. S. Centers for Disease Control and Prevention (CDC) state that vision disability is the single most prevalent disabling condition among children. Approximately 80 percent(1) of what children learn in their early school years is visual, so if they can't see a teacher's writing on the blackboard, they will struggle.(1)  American Optometric Association
'/>"/>

SOURCE PediaVision
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. PediaVision Announces Record New Orders for Revolutionary New Vision Screening Device, Spot
2. Phosphagenics to Conduct a Phase 1 Transdermal Oxycodone Clinical Trial
3. Tezampanel, TorreyPines Therapeutics Lead Compound, Reduced Muscle Spasticity and Rigidity in Preclinical Study Conducted at University of California, San Diego
4. Northwest Biotherapeutics Conducting Ovarian Cancer Clinical Trial With DCVax(R)-L at University of Pennsylvania
5. Peregrine Pharmaceuticals Receives Approval to Conduct a Phase II Trial of Bavituximab in Patients With Non-Small Cell Lung Cancer
6. Peregrine Pharmaceuticals Receives Approval to Conduct a Second Phase II Trial of Bavituximab in Patients With Advanced Breast Cancer
7. Maine Natural Health Company Conducts Dental Clinical Trial
8. Access Pharmaceuticals to Conduct Conference Call to Update Financial Community
9. Vical Receives NIH Grant for an Immunotherapeutic Herpes DNA Vaccine; Herpes Experts at University of Washington and University of Texas to Conduct Preclinical Development
10. Tibotec Conducts Two Pivotal Phase III Clinical Trials Studying TMC278 in Treatment-Naive Adults with HIV
11. Aon: Complex Insurance Requirements, Risk Management Needs Challenge Firms Conducting Clinical Trials Beyond Own Borders
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/19/2017)... 19, 2017  Sorrento Therapeutics, Inc. (NASDAQ: ... company developing new treatments for cancer and other ... its previously announced underwritten public offering of 23,625,084 ... offering price of $2.00 per share, before deducting ... payable by Sorrento.  The net proceeds to Sorrento ...
(Date:4/19/2017)... April 19, 2017  Novartis today announced the ... Heart, Lung, and Blood Institute (NHLBI) of the ... of patients with treatment-naïve severe aplastic anemia (SAA) ... with eltrombopag at the initiation of and concurrently ... evaluated three sequential treatment groups, or cohorts. Cohort ...
(Date:4/18/2017)... Cogentix Medical, Inc. (NASDAQ: CGNT), a global medical device ... markets with innovative and proprietary products, will release financial ... after the market close on Tuesday, May 2, 2017. ... call and webcast to discuss its financial results the ... p.m. Eastern Time (3:30 p.m. Central Time). Darin ...
Breaking Medicine Technology:
(Date:4/26/2017)... , ... April 26, 2017 , ... ... to improve the profitability of ready-to-drink, high-protein beverages by helping beverage manufacturers more ... to dairy proteins, providing direct cost savings as well as more stable pricing ...
(Date:4/25/2017)... ... April 25, 2017 , ... ... announces Mirroring360 Pro . This new addition to the Mirroring360 product family ... education and business. , Mirroring360 Pro enables educators, business professionals and individuals to ...
(Date:4/25/2017)... ... April 25, 2017 , ... As ... decision-makers are preparing for how his administration could impact the employee benefits industry. ... what changes are most likely to make it through Congress. His discussion will ...
(Date:4/25/2017)... Vegas, NV (PRWEB) , ... April 25, 2017 ... ... can now choose a modern procedure that achieves results in a fraction of ... in Las Vegas, NV, with Significance Dental Specialists, now offers this revolutionary ...
(Date:4/25/2017)... ... April 25, 2017 , ... Buyers and sellers in the ... dispensaries and head shops –can’t help but be heartened by the industry’s current surge. ... odor aptly described as “skunk smell.” At last they can simply, safely and ...
Breaking Medicine News(10 mins):